1. Home
  2. KVUE vs WTW Comparison

KVUE vs WTW Comparison

Compare KVUE & WTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$18.51

Market Cap

33.1B

ML Signal

HOLD

Logo Willis Towers Watson Public Limited Company

WTW

Willis Towers Watson Public Limited Company

HOLD

Current Price

$293.92

Market Cap

27.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVUE
WTW
Founded
2022
1828
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Specialty Chemicals
Specialty Insurers
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
33.1B
27.4B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
KVUE
WTW
Price
$18.51
$293.92
Analyst Decision
Buy
Buy
Analyst Count
12
14
Target Price
$19.58
$374.57
AVG Volume (30 Days)
62.2M
1.1M
Earning Date
02-17-2026
02-03-2026
Dividend Yield
4.44%
1.28%
EPS Growth
35.31
N/A
EPS
0.75
16.26
Revenue
$15,006,000,000.00
$9,708,000,000.00
Revenue This Year
N/A
$9.45
Revenue Next Year
$2.72
$6.02
P/E Ratio
$25.01
$17.70
Revenue Growth
N/A
N/A
52 Week Low
$14.02
$275.60
52 Week High
$25.17
$352.79

Technical Indicators

Market Signals
Indicator
KVUE
WTW
Relative Strength Index (RSI) 66.60 39.06
Support Level $17.96 $275.60
Resistance Level $18.97 $344.99
Average True Range (ATR) 0.37 12.14
MACD 0.08 -3.47
Stochastic Oscillator 72.57 27.31

Price Performance

Historical Comparison
KVUE
WTW

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

About WTW Willis Towers Watson Public Limited Company

Willis Towers Watson PLC is an advisory, broking, and solutions company that provides data-driven, insight-led solutions in the areas of people, risk, and capital. The company's segments include Health, Wealth & Career (HWC) and Risk & Broking (R&B). The HWC segment provides an array of advice, broking, solutions and technology for employee benefit plans, institutional investors, compensation and career programs, and employee experience overall. It focuses on four key areas: Health, Wealth, Career and Benefits Delivery & Outsourcing. The R&B segment provides risk advice, insurance brokerage and consulting services to clients ranging from small businesses to multinational corporations. Its R&B segment includes two businesses: Corporate Risk & Broking and Insurance Consulting and Technology.

Share on Social Networks: